154 related articles for article (PubMed ID: 38448141)
1. Genome-based solutions for managing mucormycosis.
Tomer R; Patiyal S; Kaur D; Choudhury S; Raghava GPS
Adv Protein Chem Struct Biol; 2024; 139():383-403. PubMed ID: 38448141
[TBL] [Abstract][Full Text] [Related]
2. A Web-Based Platform on Coronavirus Disease-19 to Maintain Predicted Diagnostic, Drug, and Vaccine Candidates.
Patiyal S; Kaur D; Kaur H; Sharma N; Dhall A; Sahai S; Agrawal P; Maryam L; Arora C; Raghava GPS
Monoclon Antib Immunodiagn Immunother; 2020 Dec; 39(6):204-216. PubMed ID: 33136473
[TBL] [Abstract][Full Text] [Related]
3. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
4. Current treatments against mucormycosis and future directions.
Smith C; Lee SC
PLoS Pathog; 2022 Oct; 18(10):e1010858. PubMed ID: 36227854
[TBL] [Abstract][Full Text] [Related]
5. An extensive review on antifungal approaches in the treatment of mucormycosis.
Chaudhari HS; Palkar OS; Abha Mishra KM; Sethi KK
J Biochem Mol Toxicol; 2023 Sep; 37(9):e23417. PubMed ID: 37345721
[TBL] [Abstract][Full Text] [Related]
6. Genetic Manipulation in Mucorales and New Developments to Study Mucormycosis.
Lax C; Cánovas-Márquez JT; Tahiri G; Navarro E; Garre V; Nicolás FE
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408814
[TBL] [Abstract][Full Text] [Related]
7. In silico tools and databases for designing cancer immunotherapy.
Dhall A; Jain S; Sharma N; Naorem LD; Kaur D; Patiyal S; Raghava GPS
Adv Protein Chem Struct Biol; 2022; 129():1-50. PubMed ID: 35305716
[TBL] [Abstract][Full Text] [Related]
8. Mucormycosis after Coronavirus disease 2019 infection in a heart transplant recipient - Case report and review of literature.
Khatri A; Chang KM; Berlinrut I; Wallach F
J Mycol Med; 2021 Jun; 31(2):101125. PubMed ID: 33857916
[TBL] [Abstract][Full Text] [Related]
9. Successful nonoperative management of gastrointestinal mucormycosis: novel therapy for invasive disease.
Mezhir JJ; Mullane KM; Zarling J; Satoskar R; Pai RK; Roggin KK
Surg Infect (Larchmt); 2009 Oct; 10(5):447-51. PubMed ID: 19485785
[TBL] [Abstract][Full Text] [Related]
10. Mucormycosis, past and present: a comprehensive review.
Gupta I; Baranwal P; Singh G; Gupta V
Future Microbiol; 2023 Feb; 18():217-234. PubMed ID: 36970978
[TBL] [Abstract][Full Text] [Related]
11. Mucormycosis: The hidden and forgotten disease.
Darwish RM; AlMasri M; Al-Masri MM
J Appl Microbiol; 2022 Jun; 132(6):4042-4057. PubMed ID: 35156271
[TBL] [Abstract][Full Text] [Related]
12. Drug repurposing of triazoles against mucormycosis using molecular docking: A short communication.
Mhatre S; Patravale V
Comput Biol Med; 2021 Sep; 136():104722. PubMed ID: 34358995
[TBL] [Abstract][Full Text] [Related]
13. ECMM/ISHAM recommendations for clinical management of COVID-19 associated mucormycosis in low- and middle-income countries.
Rudramurthy SM; Hoenigl M; Meis JF; Cornely OA; Muthu V; Gangneux JP; Perfect J; Chakrabarti A;
Mycoses; 2021 Sep; 64(9):1028-1037. PubMed ID: 34133816
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology, Risk Factors, Diagnosis and Treatment of Mucormycosis (Black Fungus): A Review.
Upadhayay P; Bansal K; Goyal A
Curr Pharm Biotechnol; 2023; 24(13):1645-1656. PubMed ID: 36941816
[TBL] [Abstract][Full Text] [Related]
15. COVID-19-associated mucormycosis: Evidence-based critical review of an emerging infection burden during the pandemic's second wave in India.
Aranjani JM; Manuel A; Abdul Razack HI; Mathew ST
PLoS Negl Trop Dis; 2021 Nov; 15(11):e0009921. PubMed ID: 34793455
[TBL] [Abstract][Full Text] [Related]
16. Mucormycosis, The Deadly New Worry to COVID-19 Pandemic.
Kamrul-Hasan AB; Selim S
Mymensingh Med J; 2021 Jul; 30(3):874-880. PubMed ID: 34226483
[TBL] [Abstract][Full Text] [Related]
17. SalivaDB-a comprehensive database for salivary biomarkers in humans.
Arora A; Kaur D; Patiyal S; Kaur D; Tomer R; Raghava GPS
Database (Oxford); 2023 Feb; 2023():. PubMed ID: 36747479
[TBL] [Abstract][Full Text] [Related]
18. Rhinocerebral maxillary mucormycosis: A palatal ulcer.
V Ramesh DNS; Anjum G; Rukmangada T; Patil N
Indian J Dent Res; 2020; 31(4):652-655. PubMed ID: 33107473
[TBL] [Abstract][Full Text] [Related]
19. Breaking the Mold: A Review of Mucormycosis and Current Pharmacological Treatment Options.
Riley TT; Muzny CA; Swiatlo E; Legendre DP
Ann Pharmacother; 2016 Sep; 50(9):747-57. PubMed ID: 27307416
[TBL] [Abstract][Full Text] [Related]
20. Computer-Aided Tools and Resources for Fungal Pathogens: An Application of Reverse Vaccinology for Mucormycosis.
Bhargav A; Fatima F; Chaurasia P; Seth S; Ramachandran S
Monoclon Antib Immunodiagn Immunother; 2022 Oct; 41(5):243-254. PubMed ID: 35939284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
